-
1
-
-
8544247938
-
-
Aggarwal 2004 Aggarwal R, Ranjan P. Preventing and treating hepatitis B infection. BMJ (Clinical Research Ed.) 2004;329:1080- 6.
-
Aggarwal 2004 Aggarwal R, Ranjan P. Preventing and treating hepatitis B infection. BMJ (Clinical Research Ed.) 2004;329:1080- 6.
-
-
-
-
2
-
-
44949235041
-
-
Als-Nielsen 2004 Als-Nielsen B, Gluud LL, Gluud C. Methodological quality and treatments effects in randomised trials - a review of six emperical studies (abstract). 12th Cochrane Colloquium, Ottawa, Canada (http://www.cochrane.org/colloquia/abstracts/ottawa/); abstract book: O-072: 2004.
-
Als-Nielsen 2004 Als-Nielsen B, Gluud LL, Gluud C. Methodological quality and treatments effects in randomised trials - a review of six emperical studies (abstract). 12th Cochrane Colloquium, Ottawa, Canada (http://www.cochrane.org/colloquia/abstracts/ottawa/); abstract book: O-072: 2004.
-
-
-
-
3
-
-
0037464808
-
-
Altman 2003 Altman DG, Bland JM. Interaction revisited: the difference between two estimates. BMJ (Clinical Research Ed.) 2003;326:219.
-
Altman 2003 Altman DG, Bland JM. Interaction revisited: the difference between two estimates. BMJ (Clinical Research Ed.) 2003;326:219.
-
-
-
-
4
-
-
0021431353
-
-
Beasley 1984 Beasley RP, Hwang LY. Hepatocellular carcinoma and hepatitis B virus. Seminars in Liver Disease 1984;4:113-21.
-
Beasley 1984 Beasley RP, Hwang LY. Hepatocellular carcinoma and hepatitis B virus. Seminars in Liver Disease 1984;4:113-21.
-
-
-
-
5
-
-
0005594538
-
Recommendations to prevent hepatitis B virus transmission-United States, updated
-
CDC 1999 Centers for Disease Control and Prevention
-
CDC 1999 Centers for Disease Control and Prevention. Recommendations to prevent hepatitis B virus transmission-United States, updated. MMWR. Morbidity and Mortality Weekly Report 1999;48:33-4.
-
(1999)
MMWR. Morbidity and Mortality Weekly Report
, vol.48
, pp. 33-34
-
-
-
6
-
-
85136399305
-
-
Chen 1996 Chen HL, Chang MH, Ni YH, Hsu HY, Lee PI, Lee CY, et al.Seroepidemiology of hepatitis B virus infection in children: ten years of mass vaccination in Taiwan. JAMA 1996;276:906-8.
-
Chen 1996 Chen HL, Chang MH, Ni YH, Hsu HY, Lee PI, Lee CY, et al.Seroepidemiology of hepatitis B virus infection in children: ten years of mass vaccination in Taiwan. JAMA 1996;276:906-8.
-
-
-
-
7
-
-
84921431302
-
-
Chen 2005 Chen W, Gluud C. Vaccines for preventing hepatitis B in health-care workers. Cochrane Database of Systematic Reviews 2005, Issue 4. Art. No.: CD000100. DOI: 10.1002/14651858.CD000100.pub3.
-
Chen 2005 Chen W, Gluud C. Vaccines for preventing hepatitis B in health-care workers. Cochrane Database of Systematic Reviews 2005, Issue 4. Art. No.: CD000100. DOI: 10.1002/14651858.CD000100.pub3.
-
-
-
-
8
-
-
44949116469
-
-
Gluud 2006 Gluud C, Als-Nielsen B, D'Amico G, Fingerhut A, Gluud LL, Khan S, et al.Cochrane Hepato-Biliary Group. About The Cochrane Collaboration (Cochrane Review Groups (CRGs)) 2006, Issue 3. Art. No.: LIVER.
-
Gluud 2006 Gluud C, Als-Nielsen B, D'Amico G, Fingerhut A, Gluud LL, Khan S, et al.Cochrane Hepato-Biliary Group. About The Cochrane Collaboration (Cochrane Review Groups (CRGs)) 2006, Issue 3. Art. No.: LIVER.
-
-
-
-
9
-
-
0041876133
-
-
Higgins 2003 Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analysis. BMJ (Clinical Research Ed.) 2003;327(7414):557-60.
-
Higgins 2003 Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analysis. BMJ (Clinical Research Ed.) 2003;327(7414):557-60.
-
-
-
-
10
-
-
44949175345
-
-
Higgins 2006 Higgins JPT, Green S. Cochrane Handbook for Systematic Reviews of Interventions 4.2.6 [updated September 2006]. The Cochrane Library, Issue 4, 2006. Chichester, UK: John Wiley & sons, Ltd.
-
Higgins 2006 Higgins JPT, Green S. Cochrane Handbook for Systematic Reviews of Interventions 4.2.6 [updated September 2006]. The Cochrane Library, Issue 4, 2006. Chichester, UK: John Wiley & sons, Ltd.
-
-
-
-
11
-
-
44949201974
-
-
ICH-GCP 1997 International Conference on Harmonisation of Technical Requiements for Registration of Pharmaceuticals for Human Use. Code of Federal Regulation & ICH Guidelines. Media: Parexel Barnett, 1997.
-
ICH-GCP 1997 International Conference on Harmonisation of Technical Requiements for Registration of Pharmaceuticals for Human Use. Code of Federal Regulation & ICH Guidelines. Media: Parexel Barnett, 1997.
-
-
-
-
12
-
-
44949137716
-
-
Jüni 2001 Jüni P, Douglas GA, Egger M. Assessing the quality of controlled clinical trials. BMJ (Clinical Research Ed.) 2001;323:42-46.
-
Jüni 2001 Jüni P, Douglas GA, Egger M. Assessing the quality of controlled clinical trials. BMJ (Clinical Research Ed.) 2001;323:42-46.
-
-
-
-
13
-
-
0035808035
-
-
Kjaergard 2001 Kjaergard LL, Villumsen J, Gluud C. Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses. Annals of Internal Medicine 2001;135(11):982-9.
-
Kjaergard 2001 Kjaergard LL, Villumsen J, Gluud C. Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses. Annals of Internal Medicine 2001;135(11):982-9.
-
-
-
-
14
-
-
33745039758
-
-
Lee 2006 Lee C, Gong Y, Brok J, Boxall E, Gluud C. Hepatitis B immunisation for newborn infants of hepatitis B surface antigen-positive mothers. Cochrane Database of Systematic Reviews 2006, Issue 2. Art. No.: CD004790. DOI: 10.1002/14651858.CD004790.pub2.
-
Lee 2006 Lee C, Gong Y, Brok J, Boxall E, Gluud C. Hepatitis B immunisation for newborn infants of hepatitis B surface antigen-positive mothers. Cochrane Database of Systematic Reviews 2006, Issue 2. Art. No.: CD004790. DOI: 10.1002/14651858.CD004790.pub2.
-
-
-
-
15
-
-
32844458617
-
-
Lee 2006a Lee C, Gong Y, Brok J, Boxall EH, Gluud C. Effect of hepatitis B immunisation in newborn infants of mothers positive for hepatitis B surface antigen: systematic review and meta-analysis. BMJ (Clinical Research Ed.) 2006;332(7537):328-36.
-
Lee 2006a Lee C, Gong Y, Brok J, Boxall EH, Gluud C. Effect of hepatitis B immunisation in newborn infants of mothers positive for hepatitis B surface antigen: systematic review and meta-analysis. BMJ (Clinical Research Ed.) 2006;332(7537):328-36.
-
-
-
-
16
-
-
0023762809
-
-
Liaw 1998 Liaw YF, Tai DI, Chu CM, Chen TJ. The development of cirrhosis in patients with chronic type B hepatitis: a prospective study. Hepatology 1988;8:493-6.
-
Liaw 1998 Liaw YF, Tai DI, Chu CM, Chen TJ. The development of cirrhosis in patients with chronic type B hepatitis: a prospective study. Hepatology 1988;8:493-6.
-
-
-
-
17
-
-
0022000510
-
-
MacMahon 1985 MacMahon BJ, Alward WL, Hall DB, Heyward WL, Bender TR, Francis DP, et al.Acute hepatitis B virus infection: relation of age to the clinical expression of disease and subsequent development of carrier state. The Journal of Infectious Diseases 1985;151:599-603.
-
MacMahon 1985 MacMahon BJ, Alward WL, Hall DB, Heyward WL, Bender TR, Francis DP, et al.Acute hepatitis B virus infection: relation of age to the clinical expression of disease and subsequent development of carrier state. The Journal of Infectious Diseases 1985;151:599-603.
-
-
-
-
18
-
-
0032558314
-
-
Moher 1998 Moher D, Pham B, Jones A, Cook DJ, Jadad AR, Moher M, et al.Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analysis. Lancet 1998;352:609-13.
-
Moher 1998 Moher D, Pham B, Jones A, Cook DJ, Jadad AR, Moher M, et al.Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analysis. Lancet 1998;352:609-13.
-
-
-
-
19
-
-
44949174403
-
-
Nystrom 2000 Nystrom RJ, Timmons AJ. Completion of hepatitis B vaccination series in school-based health centers. The Journal of Adolescent Health 2000;26:320-1.
-
Nystrom 2000 Nystrom RJ, Timmons AJ. Completion of hepatitis B vaccination series in school-based health centers. The Journal of Adolescent Health 2000;26:320-1.
-
-
-
-
20
-
-
0037325472
-
-
Rehermann 2003 Rehermann B. Immune responses in hepatitis virus infection. Seminars in Liver Disease 2003;23:21-38.
-
Rehermann 2003 Rehermann B. Immune responses in hepatitis virus infection. Seminars in Liver Disease 2003;23:21-38.
-
-
-
-
21
-
-
44949227355
-
-
RevMan 2003 Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). 4.2 for Windows. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2003.
-
RevMan 2003 Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). 4.2 for Windows. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2003.
-
-
-
-
22
-
-
0036267455
-
-
Rizzetto 2002 Rizzetto M, Zanetti AR. Progress in the prevention and control of viral hepatitis B. Closing remarks. Journal of Medical Virology 2002; 67:463-6.
-
Rizzetto 2002 Rizzetto M, Zanetti AR. Progress in the prevention and control of viral hepatitis B. Closing remarks. Journal of Medical Virology 2002; 67:463-6.
-
-
-
-
23
-
-
0344596063
-
-
Royle 2003 Royle P, Milne R. Literature searching for randomized controlled trials used in Cochrane reviews: rapid versus exhaustive searches. International Journal of Technology Assessment in Health Care 2003; 19(4):591-603.
-
Royle 2003 Royle P, Milne R. Literature searching for randomized controlled trials used in Cochrane reviews: rapid versus exhaustive searches. International Journal of Technology Assessment in Health Care 2003; 19(4):591-603.
-
-
-
-
24
-
-
16544375385
-
-
Schroth 2004 Schroth RJ, Hitchon CA, Uhanova J, Noreddin A, Taback SP, Moffatt MEK, et al.Hepatitis B vaccination for patients with chronic renal failure. Cochrane Database of Systematic Reviews 2004, Issue 3. Art. No.: CD003775. DOI: 10.1002/14651858.CD003775.pub2.
-
Schroth 2004 Schroth RJ, Hitchon CA, Uhanova J, Noreddin A, Taback SP, Moffatt MEK, et al.Hepatitis B vaccination for patients with chronic renal failure. Cochrane Database of Systematic Reviews 2004, Issue 3. Art. No.: CD003775. DOI: 10.1002/14651858.CD003775.pub2.
-
-
-
-
25
-
-
85047692188
-
-
Schulz 1995 Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995;273:408-12.
-
Schulz 1995 Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995;273:408-12.
-
-
-
-
26
-
-
0030979062
-
-
Van Damme 1997 Van Damme P, Kane M, Meheus A on behalf of the Viral Hepatitis Prevention Board. Integration of hepatitis B vaccination into national immunisation programmes. BMJ (Clinical Research Ed.) 1997;314:1033.
-
Van Damme 1997 Van Damme P, Kane M, Meheus A on behalf of the Viral Hepatitis Prevention Board. Integration of hepatitis B vaccination into national immunisation programmes. BMJ (Clinical Research Ed.) 1997;314:1033.
-
-
-
-
27
-
-
1642337523
-
-
WHO 2004 World Health Organisation, Accessed February 2007 2004
-
WHO 2004 World Health Organisation. Hepatitis B. http://www.who.int/mediacentre/factsheets/fs204/en/ (Accessed February 2007) 2004.
-
Hepatitis B
-
-
-
28
-
-
0028019341
-
-
Wong 1994 Wong VK, Woodruff C, Shapiro R. Compliance of hepatitis B vaccination in patients presenting to a teenage clinic. The Pediatric Infectious Disease Journal 1994;13:936.
-
Wong 1994 Wong VK, Woodruff C, Shapiro R. Compliance of hepatitis B vaccination in patients presenting to a teenage clinic. The Pediatric Infectious Disease Journal 1994;13:936.
-
-
-
|